|
|
Post by cretin11 on Nov 22, 2019 16:29:46 GMT -5
Interesting poll results. As of this moment, 13 of the 70 respondents say we'll be above $5 within three months.
Are those serious responses?! If so, must be folks who are extremely new to MNKD, and even then, I want some of what they're smoking.
(I voted for 5 years, and that's not intended to be pessimistic, as I could live with that slow timeline. Have waited five years for share price to go from $50 to $1, so five years to get back up to $5 doesn't seem so bad by comparison.)
|
|
|
|
Post by mnholdem on Nov 22, 2019 16:31:21 GMT -5
Gee thanks, mytake... now I’m gonna be humming that song all afternoon. ;-)
|
|
|
|
Post by sportsrancho on Nov 22, 2019 16:41:39 GMT -5
Interesting poll results. As of this moment, 13 of the 70 respondents say we'll be above $5 within three months. Are those serious responses?! If so, must be folks who are extremely new to MNKD, and even then, I want some of what they're smoking. (I voted for 5 years, and that's not intended to be pessimistic, as I could live with that slow timeline. Have waited five years for share price to go from $50 to $1, so five years to get back up to $5 doesn't seem so bad by comparison.) Maybe those 13 never post and they know something we don’t🤣🤷♀️ |
|
|
|
Post by ktim on Nov 22, 2019 17:14:35 GMT -5
If there had been an option for Monday I think a good portion of those 13 probably would have picked that. For some, MNKD is always on the verge of revealing the great news they are hiding... it's coming any day now. One just has to connect the dots and have faith. Anything could happen between now and Monday  |
|
|
|
Post by mytakeonit on Nov 22, 2019 18:11:49 GMT -5
ktim - you must be joking.  But, if you said Tuesday then maybe it might happen. Ha! BTW, what month are we talking about? But, that's mytakeonit |
|
|
|
Post by mytakeonit on Nov 22, 2019 18:24:50 GMT -5
BTW, this poll closes on Nov. 27th. Does this mean that the 3 months end is like for our next conference call AND around Leap Year Day ?!!! Wow !!! My wife and I started dating on Leap Year Day maybe 200 years ago ... and factoring in dementia.
But, that's mytakeonit
|
|
|
|
Post by falconquest on Nov 22, 2019 20:23:11 GMT -5
I don't know, the price has languished just above a dollar for so long, it's going to take a major catalyst to bump it to $5. If it's a one time event then the price will bounce but settle back down. The only way it sustains over $5 is if all of a sudden Afrezza catches fire and really starts selling. I don't think that will happen. I think it will be a slow steady progression. GLTA
|
|
|
|
Post by sexychefski on Nov 22, 2019 20:49:03 GMT -5
Can I change my vote to within 4 months?
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Nov 23, 2019 1:23:09 GMT -5
Can I change my vote to within 4 months? There are 3 catalysts that will propel the stock price in the near term (1H20). 1. Pediatric Phase 3 Trial Submission (Effect: $.75 increase) 2. New Classification (ULTRA) (Effect: $2.50 increase) (Possible Short Covering) 3. New Deal on Secret Molecule or New Drug Partnership (Poss. EPIHALE) (Effect: $1.50 increase) |
|
|
|
Post by sportsrancho on Nov 23, 2019 7:06:25 GMT -5
👍🏻I agree and would also add Vdex expansion. $.50
$5.25😎
|
|
|
|
Post by winner on Nov 23, 2019 7:28:18 GMT -5
5. Positive news from RLS. (Effect >$1.00) >$6.25
|
|
|
|
Post by sportsrancho on Nov 23, 2019 7:46:49 GMT -5
#6....In my opinion what we lack is funds and retention.
It could be priced in, or there could be some downside to missing the covenants and MC using the ATM after he gets the shares back from the warrants that won’t be exercised.
Getting some new blood on the board that can think outside of the box as far as a Afrezza. Compensation overhaul, strategic planning. Overseas deals. Too many asleep at the wheel and just going with the status quo. Getting the label change is going to affect the share price at the moment, but will it fix the retention ...highly doubtful. Input from Bill /Vdex on retention... Priceless
2021 $10🤞
|
|
|
|
Post by hellodolly on Nov 23, 2019 8:12:33 GMT -5
#6....In my opinion what we lack is funds and retention. It could be priced in, or there could be some downside to missing the covenants and MC using the ATM after he gets the shares back from the warrants that won’t be exercised. Getting some new blood on the board that can think outside of the box as far as a Afrezza. Compensation overhaul, strategic planning. Overseas deals. Too many asleep at the wheel and just going with the status quo. Getting the label change is going to affect the share price at the moment, but will it fix the retention ...highly doubtful. Input from Bill /Vdex on retention... Priceless 2021 $10🤞 Secret of Vdex retention = Free samples, free samples and more free samples. Hell yeah their customers love them, they don't pay for their meds as long as Bill has his samples for an extended period of time until they can get them over the same obstacles, which by the way MNKD is already aware of and have had feedback from users of Afrezza. Hell yeah, Bill needs those samples, but that's just my insignificant input. So, what happened to the other 20% who Vdex couldn't retain, I ask? That's a good question and there could be many reasons including one that the obstacles were just too big for some of the patients. I'd like to know myself, about more on the 20% they can't retain because those numbers need to improve. I can't see how MNKD, with all of their assets and resources at their disposal, around the country...haven't looked in depth at the retention and not been able to figure it out AND, Vdex has? Sports, you're such a great advocate and I really enjoy people like you who don't mind saying what's on your mind. I just can't come around to the Darkside...I love my Yoda too much. But, that doesn't mean that I'm not pushing to see more results equate into an improved SP...I just don't see Vdex as the right answer for that, yet. EDIT: I chose two years in the poll. |
|
|
|
Post by sportsrancho on Nov 23, 2019 8:58:33 GMT -5
Vdex is just one answer.
They aren’t getting any more samples than anyone else, in some cases less.. I’d like to know where you heard otherwise?
Vdex’s retention is 80% better than Mannkind’s. There’s always people that for whatever reason cannot use Afrezza or can’t get insurance.
Every time Mannkind gains in an Afrezza user.. they lose one. People are using more eight and 12 units which helps the revenue. We’ve been over time and time again why they lose them, that’s the part Vdex can help with.
I chose two years in the pole also, but then Casper changed my mind:-)
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Nov 23, 2019 10:42:58 GMT -5
#6....In my opinion what we lack is funds and retention. It could be priced in, or there could be some downside to missing the covenants and MC using the ATM after he gets the shares back from the warrants that won’t be exercised. Getting some new blood on the board that can think outside of the box as far as a Afrezza. Compensation overhaul, strategic planning. Overseas deals. Too many asleep at the wheel and just going with the status quo. Getting the label change is going to affect the share price at the moment, but will it fix the retention ...highly doubtful. Input from Bill /Vdex on retention... Priceless 2021 $10🤞 That ship has sailed. Mike has blocked any new members with the latest announcement. No one connected to VDEX will be on MNKD's board. Like Mike said there is NOTHING that Bill or VDEX has shown that warrant a position. Show me 20-30 years of upper level Big Pharma managerial experience from anyone at VDEX to justify a seat. There is NONE. |
|
But, if you said Tuesday then maybe it might happen. Ha! BTW, what month are we talking about?
